Skybridge Pharmaceuticals, Inc.

Portland, OR 97221

SBIR Award Summary

Total Number of Awards 1
Total Value of Awards $105K
First Award Date 07/15/09
Most Recent Award Date 07/15/09

Key Personnel

Last Name Name Awards Contact
Paquette Melanie A. Paquette 1

1 Award Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 07/15/09 - 01/15/10

DESCRIPTION (provided by applicant): Our objective is to develop new drug treatments for the side effects of levodopa (L-DOPA) that occur in people with Parkinson's Disease. L-DOPA is the gold standard of treatment for Parkinson's, but unfortunately, the majority of people who take L-DOPA eventually develop debilitating side effects, abnormal in...